Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery

Trial Profile

Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jan 2019

At a glance

  • Drugs Nepafenac (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Mati Therapeutics
  • Most Recent Events

    • 14 Jan 2019 Status changed from recruiting to completed.
    • 24 Sep 2018 Planned End Date changed from 1 Sep 2018 to 1 Dec 2018.
    • 24 Sep 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top